Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who were previously identified as high risk in a past study (covering 2017–2025) using a risk-assessment tool called MIRAI
- Women over 40 years of age who have been identified as high risk based on standard medical guidelines
- People whose medical records include a routine or diagnostic breast screening mammogram, along with the actual images stored in the hospital's imaging system
- People whose records include all follow-up breast imaging studies documented in the hospital system
- People who may have had a tissue sample (biopsy) taken, as long as all procedures were done at a UMass medical site and the results are recorded in the hospital's health records
Who may not be able to join:
- Women under 40 years of age, as routine mammogram screening is not standard at that age
- People whose mammogram images have technical problems, such as image corruption, artifacts, or poor image quality
- People who are pregnant, as routine screening mammograms are not standard during pregnancy
- Adult male patients with breast cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohammed Salman Shazeeb, PhD, UMass Chan Medical School
Phone: 7744417731
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CDR Mirai Assessment versus CDR Traditional High Risk Screening
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.